Likewise, in vivo administration of selenoprotein P led to hepatic and peripheral insulin resistance, while liver-specific genetic ablation significantly ameliorated systemic glucose intolerance in association with enhanced insulin signaling in the liver and skeletal muscle [12,61,62,63,64]. This evidence concerns the gene SELENOP and Insulin resistance.